Catalyst — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Harbinger Healthharbinger-health.comin𝕏Sep 2023 · $140M
Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples.
AI & Machine LearningBiotechDigital HealthHealthtech
Co-investorsFlagship Pioneering
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.